Trial intelligence / Profile preview

Topical Danazol for Pain in Fibrocystic Breast Disease

NCT00744276Phase 2Completed

Sponsor
FemmePharma
Start
Jan 2007
Primary completion
Apr 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of danazol in Fibrocystic breasts, sponsored by FemmePharma. Started Jan 2007; status: completed.

02

Drugs

danazol
03

Conditions

Fibrocystic breasts

Beyond the preview

Go deeper on NCT00744276.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00744276.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call